KR20230058291A - Novel Method for Preparing Immature Sword Bean Pod Extracts Having Increased Rutin Content and Functionality, and Immature Sword Bean Pod Extracts Prepared Thereby - Google Patents
Novel Method for Preparing Immature Sword Bean Pod Extracts Having Increased Rutin Content and Functionality, and Immature Sword Bean Pod Extracts Prepared Thereby Download PDFInfo
- Publication number
- KR20230058291A KR20230058291A KR1020220136458A KR20220136458A KR20230058291A KR 20230058291 A KR20230058291 A KR 20230058291A KR 1020220136458 A KR1020220136458 A KR 1020220136458A KR 20220136458 A KR20220136458 A KR 20220136458A KR 20230058291 A KR20230058291 A KR 20230058291A
- Authority
- KR
- South Korea
- Prior art keywords
- dodu
- extract
- functionality
- present
- pod
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 99
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 title claims abstract description 45
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 title claims abstract description 45
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 title claims abstract description 45
- 235000005493 rutin Nutrition 0.000 title claims abstract description 45
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 title claims abstract description 45
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 title claims abstract description 45
- 229960004555 rutoside Drugs 0.000 title claims abstract description 45
- 238000000034 method Methods 0.000 title claims abstract description 42
- 230000001965 increasing effect Effects 0.000 title abstract description 18
- 235000010518 Canavalia gladiata Nutrition 0.000 title description 10
- 235000010520 Canavalia ensiformis Nutrition 0.000 title description 9
- 240000001723 Entada phaseoloides Species 0.000 title 2
- 239000000203 mixture Substances 0.000 claims abstract description 45
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 29
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 26
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 26
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- 235000010469 Glycine max Nutrition 0.000 claims description 39
- 244000068988 Glycine max Species 0.000 claims description 39
- 230000036541 health Effects 0.000 claims description 29
- 239000000843 powder Substances 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 238000000605 extraction Methods 0.000 claims description 26
- 235000013376 functional food Nutrition 0.000 claims description 23
- 239000004480 active ingredient Substances 0.000 claims description 22
- 239000002904 solvent Substances 0.000 claims description 22
- 239000008194 pharmaceutical composition Substances 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 8
- 238000005119 centrifugation Methods 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 8
- 239000003674 animal food additive Substances 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000011148 porous material Substances 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 238000007602 hot air drying Methods 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 238000001291 vacuum drying Methods 0.000 claims description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 15
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 abstract description 11
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 abstract description 8
- 235000013824 polyphenols Nutrition 0.000 abstract description 8
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 7
- 230000002000 scavenging effect Effects 0.000 abstract description 5
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 description 34
- 238000009472 formulation Methods 0.000 description 20
- 239000002994 raw material Substances 0.000 description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 244000046052 Phaseolus vulgaris Species 0.000 description 12
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 12
- -1 fluoroalkanes Chemical compound 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000002156 mixing Methods 0.000 description 8
- 244000045232 Canavalia ensiformis Species 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- 235000013361 beverage Nutrition 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 235000010980 cellulose Nutrition 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229930003935 flavonoid Natural products 0.000 description 6
- 150000002215 flavonoids Chemical class 0.000 description 6
- 235000017173 flavonoids Nutrition 0.000 description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 230000002292 Radical scavenging effect Effects 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 235000012041 food component Nutrition 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000007911 parenteral administration Methods 0.000 description 5
- 235000015067 sauces Nutrition 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000005417 food ingredient Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 229940095612 bean pod extract Drugs 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 235000004515 gallic acid Nutrition 0.000 description 3
- 229940074391 gallic acid Drugs 0.000 description 3
- 229960004592 isopropanol Drugs 0.000 description 3
- 229920006008 lipopolysaccharide Polymers 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 240000003049 Canavalia gladiata Species 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical group CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 230000009194 climbing Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- LJSQFQKUNVCTIA-UHFFFAOYSA-N diethyl sulfide Chemical compound CCSCC LJSQFQKUNVCTIA-UHFFFAOYSA-N 0.000 description 2
- 239000012470 diluted sample Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000020510 functional beverage Nutrition 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940041476 lactose 100 mg Drugs 0.000 description 2
- 239000012669 liquid formulation Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N p-hydroxybenzoic acid methyl ester Natural products COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000004148 unit process Methods 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical compound CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 1
- SQCZQTSHSZLZIQ-UHFFFAOYSA-N 1-chloropentane Chemical compound CCCCCCl SQCZQTSHSZLZIQ-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- FXNDIJDIPNCZQJ-UHFFFAOYSA-N 2,4,4-trimethylpent-1-ene Chemical group CC(=C)CC(C)(C)C FXNDIJDIPNCZQJ-UHFFFAOYSA-N 0.000 description 1
- CCTFAOUOYLVUFG-UHFFFAOYSA-N 2-(1-amino-1-imino-2-methylpropan-2-yl)azo-2-methylpropanimidamide Chemical compound NC(=N)C(C)(C)N=NC(C)(C)C(N)=N CCTFAOUOYLVUFG-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- LXEKPEMOWBOYRF-QDBORUFSSA-N AAPH Chemical compound Cl.Cl.NC(=N)C(C)(C)\N=N\C(C)(C)C(N)=N LXEKPEMOWBOYRF-QDBORUFSSA-N 0.000 description 1
- 238000010269 ABTS assay Methods 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 206010038910 Retinitis Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229940037769 calcium carbonate 100 mg Drugs 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- ULYZAYCEDJDHCC-UHFFFAOYSA-N isopropyl chloride Chemical compound CC(C)Cl ULYZAYCEDJDHCC-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- SNMVRZFUUCLYTO-UHFFFAOYSA-N n-propyl chloride Chemical compound CCCCl SNMVRZFUUCLYTO-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229940078552 o-xylene Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012439 solid excipient Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940033203 vitamin b6 0.5 mg Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2116—Flavonoids, isoflavones
- A23V2250/2117—Rutin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/18—Fractionation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/34—Membrane process
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Birds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 루틴 함량 및 기능성이 증대된 도두꼬투리 추출물 제조 방법 및 이에 따라 제조된 추출물에 관한 것으로, 본 발명의 방법에 따라 제조된 루틴 함량 및 기능성이 증대된 도두꼬투리 추출물은 우수한 ABTS 소거, DPPH 소거 및 총 폴리페놀 함량 증대 효과와, 우수한 산화질소 생성 억제 효과를 나타내므로, 항산화 및 항염증 조성물로 유용하게 사용할 수 있다.The present invention relates to a method for preparing a Dodu pod extract with increased rutin content and functionality and an extract prepared thereby, wherein the Dodu pod extract with increased rutin content and functionality prepared according to the method of the present invention has excellent ABTS scavenging and DPPH scavenging And since it shows an effect of increasing the total polyphenol content and an excellent nitric oxide production inhibitory effect, it can be usefully used as an antioxidant and anti-inflammatory composition.
Description
본 발명은 루틴 함량 및 기능성이 증대된 도두꼬투리 추출물 제조 방법 및 이에 따라 제조된 추출물에 관한 것이다다.The present invention relates to a method for preparing a Dodu pod extract with increased rutin content and functionality, and an extract prepared thereby.
웰빙시대에 접어들면서 건강에 좋은 기능성식품에 대한 관심이 커지고 있고 이에 따라 곳곳의 농식품산업계에서는 인체 건강에 영향을 미치는 효능과 더불어 유용한 고급성분을 가지고 있는 식품을 창출하려는 노력이 진행되고 있으며 최근 소비자들은 바쁜 일상으로 편이가공식품을 자주 섭취하게 되고 편이가공식품을 선택할 경우는 웰에이징을 위해 건강에 도움을 줄 수 있는 기능성 소재로 만들어지거나 기능성 성분이 함유된 식품을 섭취하여 건강을 유지하고자 한다. 따라서, 소비자 니즈는 기능성분과 영양성분을 함유하고 있는 건강한 원재료로 만들어진 식품이나 식품원료 및 원산지에 대한 부분까지 확대되고 있다.As we enter the well-being era, interest in functional foods that are good for health is growing, and accordingly, efforts are being made in the agri-food industry everywhere to create foods that have useful high-quality ingredients as well as effects that affect human health. Convenience processed foods are consumed frequently due to busy daily life, and when choosing convenience processed foods, people want to maintain health by consuming foods made of functional materials or containing functional ingredients that can help health for well-aging. Therefore, consumer needs are expanding to include foods made from healthy raw materials containing functional and nutritional components, food raw materials and country of origin.
식품산업계는 이러한 소비자 트렌드를 반영하여 생리활성이 우수한 식품에 사용 가능한 기능성이 우수한 원재료 발굴과 이를 활용한 상품을 개발하는데 주력하고 있고 기능성을 포함하고 있는 다양한 상품개발과 기능성을 보유하고 있는 수입대체 국산 원료를 발굴하기 위해 노력을 기울이고 있다. Reflecting these consumer trends, the food industry is concentrating on discovering raw materials with excellent functionality that can be used for foods with excellent physiological activity and developing products using them, developing various products that include functionality and replacing domestic products with functionality. Efforts are being made to discover raw materials.
도두(작두콩, sword bean, Canavalia gladiata, Canavalia ensiformis)는 쌍떡잎식물인 장미목 콩과의 덩굴성 한해살이풀로서 콩깍지가 작두칼과 같이 생겼다고 하여 작두콩 또는 칼콩이라고 하며 국내외에서 차나 익힌 채소로 섭취해오고 있다. 콩과에 속하며 덩굴성 일년생 초본으로 주요 재배지역은 아프리카 동남아시아 등에서 재배되어지고 있으나 기후온난화로 인해 국내 도입 및 토착화되어 재배되고 있다.Dodu (sword bean, Canavalia gladiata , Canavalia ensiformis ) is a dicotyledonous plant, a climbing annual plant belonging to the rosemary legume family, and is called sword bean or sword bean because the bean pod looks like a sword bean, and has been consumed as tea or cooked vegetables at home and abroad. It belongs to the leguminous family and is a climbing annual herb. Its main cultivation area is in Africa, Southeast Asia, etc., but due to climate warming, it is introduced and cultivated in Korea.
도두는 그동안 콩알의 형태로 주로 식용하였으나 생육 특성상 8월 이후 개화 시 도두의 완숙율이 급격히 저하되기 때문에 콩알만 이용 시 노동력, 경영비 상승이 문제가 되고 무엇보다 영양성분과 기능성이 우수한 농식품이 폐기되는 문제가 있다. Soybeans have been mainly eaten in the form of soybeans, but due to the nature of their growth, the maturity rate of soybeans rapidly decreases when flowering after August. there is a problem.
이로 인해 최근 성숙 이전 상태의 도두꼬투리를 활용하자는 차원에서 식약처에서 신규 식품 원료로 등록되어 일반식품과 기능성 식품 원료로까지 개발할 수 있는 기반이 마련되었다.As a result, it was recently registered as a new food raw material by the Ministry of Food and Drug Safety in order to utilize the unripe pods, laying the groundwork for developing general food and functional food raw materials.
그러나, 최근에 신규 식품 원료로 등록된 상황이기에 아직 상용화된 제품으로서 식용한 기간이 짧아 도두꼬투리의 산업화를 위한 연구 및 기능성에 대한 연구는 이루어져 있지 않음에 따라 식품소재화 기술 및 제품개발 연구를 통해 소재의 활용성과 실용성을 증진시키는 연구가 필요하다. However, as it has recently been registered as a new food ingredient, as a commercialized product, it has not been eaten for a short period of time, so research for industrialization and functionality of Dodu pods has not been conducted. Research to improve the utilization and practicality of materials is needed.
또한, 최근 일반식품 및 농산물의 기능성 표시제가 실시됨에 따라 과학적 기초 기반 데이터 마련을 통해 국산 농산물의 세계시장 진입과 경쟁력 확보 등 국산 농산물의 세계화를 위한 소재 산업화의 노력이 필요한 실정이다.In addition, as the functional labeling system for general foods and agricultural products has recently been implemented, it is necessary to make efforts to industrialize materials for the globalization of domestic agricultural products, such as entering the global market and securing competitiveness through the preparation of scientific basis data.
신규로 등록된 식품원료 소재들은 식품학적 가치가 우수하나 산업화 연구 및 기능성 관련 연구가 미비하고 과학적 근거가 부족하기 때문에 소재의 실용화 및 식품으로 개발하는 데는 한계가 있으므로 등록된 소재들을 대상으로 생리활성 탐색을 통한 기능성 발굴과 소재의 활용성 증진을 위한 연구 확대가 절실히 필요한 것이다. Newly registered food raw materials have excellent food value, but there are limits to commercialization and development of the material as food due to insufficient industrialization research and functional research and lack of scientific basis. It is urgently needed to expand research to discover functionality and improve the usability of materials.
이러한 도두의 꼬투리인 도두꼬투리(도 1 참고)는 식약처에서 제공하는 식품 원료 DB에서 식품원료로서 연한조직을 갖는 어린(연한, 부풀기 전) 상태의 꼬투리에 한한다고 정의하고 있다. The pods of these soybeans (see FIG. 1) are defined as limited to young (soft, before swelling) pods having soft tissue as food raw materials in the food ingredient DB provided by the Ministry of Food and Drug Safety.
영양성분 및 유효한 성분을 다량 함유하고 있는 것으로 보고되어, 최근 식품원료로 신규 등록된 도두꼬투리에 대한 연구는 아직 극히 제한적이며, 국내에서는 건조 및 볶음 과정을 거쳐 차의 형태로만 소비하고 있어 음료, 제과, 제빵, 기호식품, 기능성식품, 화장품 등 다양한 상품으로의 응용에 제한적이다.Research on dodu pods, which have been reported to contain a large amount of nutrients and effective ingredients, and have recently been newly registered as food raw materials, is still extremely limited. However, it is limited in its application to various products such as baking, preference food, functional food, and cosmetics.
따라서, 고부가가치를 갖는 식품소재로 활용할 수 있는 도두꼬투리의 특정 유효 성분의 함량 및 효능을 효율적으로 증진시키는 방법을 개발함으로써, 건강기능식품 등의 식품소재로서의 활용 범위를 확대시킬 수 있다. Therefore, by developing a method for efficiently increasing the content and efficacy of a specific active ingredient in soybean pods that can be used as a food material with high added value, the range of use as a food material such as health functional food can be expanded.
이러한 상황 하에서, 본 발명자들은 식품 원료로서 유용한 소재인 도두(Canavalia gladiata (Jacq.) DC.))꼬투리 추출물의 유효성분 및 효능을 증대시키는 방법을 개발하기 위해 예의 연구 노력하였다. 그 결과, 본 발명자들은 최적 처리 조건을 통해 도두꼬투리의 유효성분인 루틴의 함량을 증대시키고, 항산화 및 항염증과 같은 기능성 효능이 증대된 추출물을 제조할 수 있음을 규명함으로써, 본 발명을 완성하였다.Under these circumstances, the present inventors intensively researched to develop an active ingredient and a method for increasing the efficacy of canavalia gladiata (Jacq.) DC.) pod extract, which is a useful material as a food raw material. As a result, the present inventors completed the present invention by identifying that it is possible to increase the content of rutin, an active ingredient of soybean pods, and prepare an extract with increased functional efficacy such as antioxidant and anti-inflammatory properties through optimal treatment conditions. .
따라서, 본 발명의 일 목적은 루틴(rutin) 함량 및 기능성이 증진된 도두꼬투리 추출물의 제조방법을 제공하는 데 있다.Accordingly, one object of the present invention is to provide a method for preparing a Dodu pod extract with enhanced rutin content and functionality.
또한, 본 발명의 또 다른 목적은 상기 방법에 의해 제조된, 루틴(rutin) 함량 및 기능성이 증진된 도두꼬투리 추출물을 제공하는 데 있다.In addition, another object of the present invention is to provide a Dodu pod extract with improved rutin content and functionality, prepared by the above method.
또한, 본 발명의 또 다른 목적은 상기 루틴(rutin) 함량 및 기능성이 증진된 도두꼬투리 추출물을 유효성분으로 포함하는 항산화 또는 항염증용 건강기능식품을 제공하는 데 있다.In addition, another object of the present invention is to provide an antioxidant or anti-inflammatory health functional food containing the rutin content and functionality of a Dodu pod extract as an active ingredient.
또한, 본 발명의 또 다른 목적은 상기 루틴(rutin) 함량 및 기능성이 증진된 도두꼬투리 추출물을 유효성분으로 포함하는 항산화 또는 항염증용 화장료 조성물을 제공하는 데 있다.In addition, another object of the present invention is to provide a cosmetic composition for anti-oxidation or anti-inflammatory use, which contains, as an active ingredient, a Dodu pod extract with enhanced rutin content and functionality.
또한, 본 발명의 또 다른 목적은 상기 루틴(rutin) 함량 및 기능성이 증진된 도두꼬투리 추출물을 유효성분으로 포함하는 항산화 및 항염증용 약학적 조성물을 제공하는 데 있다In addition, another object of the present invention is to provide a pharmaceutical composition for antioxidant and anti-inflammatory containing the rutin content and functionality of Dodu pod extract as an active ingredient.
또한, 본 발명의 또 다른 목적은 상기 루틴(rutin) 함량 및 기능성이 증진된 도두꼬투리 추출물을 유효성분으로 포함하는 항산화 및 항염증용 사료 첨가제를 제공하는 데 있다.In addition, another object of the present invention is to provide an antioxidant and anti-inflammatory feed additive containing the rutin content and functionality of a Dodu pod extract as an active ingredient.
본 발명의 다른 목적 및 이점은 하기의 발명의 상세한 설명 및 청구범위에 의해 보다 명확하게 된다.Other objects and advantages of the present invention will become more apparent from the following detailed description and claims.
본 명세서에서 사용한 용어는 단지 설명을 목적으로 사용된 것으로, 한정하려는 의도로 해석되어서는 안된다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다. 본 명세서에서, "포함하다" 또는 "가지다" 등의 용어는 명세서 상에 기재된 특징, 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다.The terms used herein are used for descriptive purposes only and should not be construed as limiting. Singular expressions include plural expressions unless the context clearly dictates otherwise. In this specification, terms such as "include" or "have" are intended to designate that there is a feature, number, step, operation, component, part, or combination thereof described in the specification, but one or more other features It should be understood that the presence or addition of numbers, steps, operations, components, parts, or combinations thereof is not precluded.
또한, 다르게 정의되지 않는 한, 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 모든 용어들은 실시예가 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미를 가지고 있다. 일반적으로 사용되는 사전에 정의되어 있는 것과 같은 용어들은 관련 기술의 문맥 상 가지는 의미와 일치하는 의미를 가지는 것으로 해석되어야 하며, 본 출원에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다.In addition, unless defined otherwise, all terms used herein, including technical or scientific terms, have the same meaning as commonly understood by a person of ordinary skill in the art to which the embodiment belongs. Terms such as those defined in commonly used dictionaries should be interpreted as having a meaning consistent with the meaning in the context of the related art, and unless explicitly defined in the present application, they should not be interpreted in an ideal or excessively formal meaning. don't
이하, 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 일 양태에 따르면, 본 발명은 도두꼬투리 건조 분말에 용매를 첨가하여 추출하는 단계를 포함하는, 하기 화학식 1의 루틴(rutin) 함량 및 기능성이 증진된 도두꼬투리 추출물의 제조방법을 제공한다:According to one aspect of the present invention, the present invention provides a method for producing an extract of Dodu pod with enhanced rutin content and functionality of Formula 1, comprising the step of extracting by adding a solvent to dry powder of Dodu pod :
[화학식 1][Formula 1]
. .
상기 기능성은 항산화 활성 및 항염증 활성이다.The functionalities are antioxidant activity and anti-inflammatory activity.
본 발명의 일 실시예에 따르면, 본 발명의 제조방법은 추출 단계를 실시하기 전에 도두꼬투리를 당업계에 공지된 임의의 방법으로 선별, 세척 및 건조하는 단계를 포함할 수 있다. According to one embodiment of the present invention, the manufacturing method of the present invention may include the steps of sorting, washing, and drying the soybean pods by any method known in the art before performing the extraction step.
또한, 본 발명의 일 실시예에 따르면, 본 발명은, 상기 추출 단계 이후 상기 추출된 추출액을 여과하는 단계; 및 상기 여과액을 건조하여 분말화하는 단계;를 추가적으로 포함할 수 있다.In addition, according to one embodiment of the present invention, the present invention, the step of filtering the extracted extract after the extraction step; And drying the filtrate to powder; may additionally include.
보다 구체적으로, 상기 목적을 달성하기 위한 본 발명의 추출물을 제조하는 방법은 선별, 세척한 도두꼬투리의 수분을 제거하는 단계; 상기 수분이 제거된 도두꼬투리를 절단 후 건조 분말화시키는 단계; 상기 건조된 도두꼬투리 분말에 용매를 첨가한 후 추출하는 단계; 상기 추출된 추출액을 원심분리 후 여과하는 단계; 및 상기 여과액을 건조하여 분말화하는 단계;를 포함할 수 있다.More specifically, the method for preparing the extract of the present invention for achieving the above object includes removing moisture from the selected and washed soybean pods; Cutting the water-removed soybean pods and then drying and powdering them; Extracting after adding a solvent to the dried bean pod powder; Filtering the extracted extract after centrifugation; and drying and pulverizing the filtrate.
상기 도두꼬투리는 0.3 내지 5 cm로 절단시킬 수 있고, 50 내지 120℃에서 1 내지 96시간 동안 건조시킬 수 있다.The soybean pods can be cut into 0.3 to 5 cm, and dried at 50 to 120 ° C for 1 to 96 hours.
상기 추출 단계에서 용매는 건조된 도두꼬투리 100 중량부에 대하여 500 내지 5,000중량부로 첨가될 수 있다.In the extraction step, the solvent may be added in an amount of 500 to 5,000 parts by weight based on 100 parts by weight of the dried flax pods.
상기 추출시간은 1 내지 100 시간 동안 수행될 수 있으며, 추출 온도는 10 내지 120℃일 수 있다.The extraction time may be performed for 1 to 100 hours, and the extraction temperature may be 10 to 120 °C.
상기 원심분리는 1,000 내지 10,000 g로 1 내지 30분 동안 수행될 수 있다. The centrifugation may be performed for 1 to 30 minutes at 1,000 to 10,000 g.
상기 여과막의 공극 크기(pore size)는 0.01 내지 10 ㎛일 수 있다.The pore size of the filtration membrane may be 0.01 to 10 μm.
상기 분말화는 분무건조, 동결건조, 진공건조, 열풍건조 방법일 수 있다.The powdering may be spray-dried, freeze-dried, vacuum-dried, or hot-air-dried.
상기 도두꼬투리는 도구각 또는 도두일 수 있다.The dodu pod may be a tool angle or a dodu.
본 발명은 도두꼬투리로부터 루틴(rutin) 함량 및 기능성이 증진된 추출물을 제조하는 방법에 대한 것으로, 상기 추출물은 식품원료로서 안전성을 확보함과 동시에 루틴 함량 및 기능성이 증진된 것이다. The present invention relates to a method for preparing an extract with enhanced rutin content and functionality from soybean pods, wherein the extract secures safety as a food ingredient and has enhanced rutin content and functionality.
본 발명의 방법에 따르면, 동일 양의 원물(도두꼬투리)로부터 루틴 함량을 탁월하게 증진시켜 수득할 수 있을 뿐만 아니라, 동일 양의 도두꼬투리 추출물을 사용하더라도, 본 발명의 방법을 처리하지 않고 추출한 도두꼬투리 추출물에 비해 우수한 항산화 및 항염증 효과를 확인하였다.According to the method of the present invention, not only can the rutin content be significantly increased from the same amount of raw material (bean pea pod), but even if the same amount of bean pod extract is used, soybean extracted without treatment by the method of the present invention Excellent antioxidant and anti-inflammatory effects were confirmed compared to the pod extract.
본 명세서에서 도두꼬투리 추출물을 언급하면서 사용되는 용어 '추출물'은 도두꼬투리에 본 발명의 단계 처리 후 추출 용매를 처리하여 얻은 추출 결과물뿐만 아니라 도두꼬투리 추출물 자체를 동물에게 투여할 수 있도록 제형화(예컨대, 분말화)된 도두꼬투리 가공물도 포함하는 의미를 갖는다.In this specification, the term 'extract' used while referring to the Dodu pod extract refers to formulations (e.g., , Powdered) has the meaning of including processed bean pods.
본 발명에서 이용되는 도두꼬투리 추출물을, 본 발명의 방법으로 처리된 도두꼬투리에 추출 용매를 처리하여 얻는 경우에는, 다양한 추출용매가 이용될 수 있다. 바람직하게는, 극성 용매 또는 비극성 용매를 이용할 수 있다. 극성 용매로서 적합한 것은, (i) 물, (ii) 알코올(바람직하게는, 메탄올, 에탄올, 프로판올, 부탄올, 노말-프로판올, 이소-프로판올, 노말-부탄올, 1-펜탄올, 2-부톡시에탄올 또는 에틸렌글리콜), (iii) 아세트산, (iv) DMFO(dimethyl-formamide) 및 (v) DMSO(dimethyl sulfoxide)를 포함한다. 비극성 용매로서 적합한 것은, 아세톤, 아세토나이트릴, 에틸 아세테이트, 메틸 아세테이트, 플루오로알칸, 펜탄, 헥산, 2,2,4-트리메틸펜탄, 데칸, 사이클로헥산, 사이클로펜탄, 디이소부틸렌, 1-펜텐, 1-클로로부탄, 1-클로로펜탄, o-자일렌, 디이소프로필 에테르, 2-클로로프로판, 톨루엔, 1-클로로프로판, 클로로벤젠, 벤젠, 디에틸 에테르, 디에틸 설파이드, 클로로포름, 디클로로메탄, 1,2-디클로로에탄, 어닐린, 디에틸아민, 에테르, 사염화탄소 및 THF를 포함한다.In the case where the Dodu pod extract used in the present invention is obtained by treating the Dodu pod treated with the method of the present invention with an extraction solvent, various extraction solvents may be used. Preferably, a polar solvent or a non-polar solvent may be used. Suitable as polar solvents are (i) water, (ii) alcohols (preferably methanol, ethanol, propanol, butanol, n-propanol, iso-propanol, n-butanol, 1-pentanol, 2-butoxyethanol or ethylene glycol), (iii) acetic acid, (iv) dimethyl-formamide (DMFO) and (v) dimethyl sulfoxide (DMSO). Suitable as non-polar solvents are acetone, acetonitrile, ethyl acetate, methyl acetate, fluoroalkanes, pentane, hexane, 2,2,4-trimethylpentane, decane, cyclohexane, cyclopentane, diisobutylene, 1- Penten, 1-chlorobutane, 1-chloropentane, o-xylene, diisopropyl ether, 2-chloropropane, toluene, 1-chloropropane, chlorobenzene, benzene, diethyl ether, diethyl sulfide, chloroform, dichloro methane, 1,2-dichloroethane, aniline, diethylamine, ether, carbon tetrachloride and THF.
바람직하게는, 본 발명에서 이용되는 추출용매는 (a) 물, (b) 탄소수 1-4의 무수 또는 함수 저급 알코올, (c) 상기 저급 알코올과 물과의 혼합용매, (d) 아세톤, (e) 에틸 아세테이트, (f) 클로로포름, (g) 부틸아세테이트, (h) 1,3-부틸렌글리콜, (i) 헥산 및 (j) 디에틸에테르를 포함하며, 보다 바람직하게는 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올 및 이소부탄올로 이루어진 군으로부터 선택된 1 종 이상의 탄소수 1 내지 4개의 저급 알코올이고, 가장 바람직하게는 에탄올이다.Preferably, the extraction solvent used in the present invention is (a) water, (b) anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms, (c) a mixed solvent of the lower alcohol and water, (d) acetone, ( e) ethyl acetate, (f) chloroform, (g) butyl acetate, (h) 1,3-butylene glycol, (i) hexane and (j) diethyl ether, more preferably methanol, ethanol, It is at least one lower alcohol having 1 to 4 carbon atoms selected from the group consisting of propanol, isopropanol, butanol and isobutanol, most preferably ethanol.
상기 에탄올은 10% 내지 90%(v/v) 발효주정이며, 30% 발효주정인 것이 바람직하다.The ethanol is 10% to 90% (v / v) fermented alcohol, preferably 30% fermented alcohol.
본 명세서에서 사용되는 용어 추출물은 상술한 바와 같이 당업계에서 조추출물(crude extract)로 통용되는 의미를 갖지만, 광의적으로는 추출물을 추가적으로 분획(fractionation)한 분획물도 포함한다. 즉, 도두꼬투리 추출물은 상술한 추출용매를 이용하여 얻은 것뿐만 아니라, 여기에 정제과정을 추가적으로 적용하여 얻은 것도 포함한다. 예컨대, 상기 추출물을 일정한 분자량 컷-오프 값을 갖는 한외 여과막을 통과시켜 얻은 분획, 다양한 크로마토그래피 (크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제 방법을 통해 얻어진 분획도 본 발명의 도두꼬투리 추출물에 포함되는 것이다.As used herein, the term extract has a common meaning as a crude extract in the art as described above, but also includes a fraction obtained by further fractionating the extract in a broad sense. That is, the Dodu pod extract includes not only those obtained using the above-described extraction solvent, but also those obtained by additionally applying a purification process thereto. For example, a fraction obtained by passing the extract through an ultrafiltration membrane having a certain molecular weight cut-off value, separation by various chromatography (made for separation according to size, charge, hydrophobicity or affinity), etc. The fraction obtained through the purification method is also included in the Dodu pod extract of the present invention.
본 발명에서 이용되는 도두꼬투리 추출물은 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조될 수 있다.The Dodu pod extract used in the present invention may be prepared in a powder state by an additional process such as distillation under reduced pressure and freeze drying or spray drying.
본 발명에서, 본 발명의 도두꼬투리 추출물을 제조하는 방법은 선별, 세척한 도두꼬투리의 수분을 제거하는 단계; 상기 수분이 제거된 도두꼬투리를 절단 후 건조분말화시키는 단계; 상기 건조된 도두꼬투리 분말에 용매를 첨가한 후 추출하는 단계; 상기 추출된 추출액을 원심분리 후 여과하는 단계; 및 상기 여과액을 건조하여 분말화하는 단계;를 포함할 수 있다. In the present invention, the method for preparing the extract of the Dodu pods of the present invention includes the steps of removing moisture from the selected and washed Dodu pods; Cutting the water-removed soybean pods and then drying them into powder; Extracting after adding a solvent to the dried bean pod powder; Filtering the extracted extract after centrifugation; and drying and pulverizing the filtrate.
먼저, 도두꼬투리를 폭기형 또는 와류형 세척기로 1 내지 2 분 동안 세척한 후 상기 세척된 도두꼬투리의 수분을 에어 브로워(Air brower)로 제거한다.First, the soybean pods are washed with an aeration type or swirl type washer for 1 to 2 minutes, and then the water in the washed soybean pods is removed with an air brower.
상기 도두꼬투리의 표면에 잔류되어 있는 농약성분, 중금속, 공팡이 등은 폭기형 또는 와류형 세척기를 통해 제거된다.Pesticide components, heavy metals, fungi, etc. remaining on the surface of the pods are removed through an aeration type or swirl type washer.
상기 세척된 도두꼬투리 표면의 수분함량이 2 내지 10%가 되도록 수분을 제거해야 하는데, 에어 브로워(Air brower)로 상기 수분함량 범위에 만족할 정도로 수분이 제거되지 않는 경우에는 40 내지 60℃의 건조기에 투입하여 1 내지 2 시간 동안 건조시켜 상기 수분함량을 갖는 도두꼬투리를 얻는다.Water must be removed so that the water content on the surface of the washed soybean pods is 2 to 10%. It is added and dried for 1 to 2 hours to obtain a bean pod having the above moisture content.
도두꼬투리의 수분함량이 상기 하한치 미만인 경우에는 에어 브로워로 수분을 제거 시 껍질 일부가 제거될 수 있으며, 상기 상한치 초과인 경우에는 이후에 수행되는 건조시간이 길어져 작업성이 저하되고 조직이 단단해질 수 있다.If the moisture content of the pods is less than the lower limit above, some of the skin may be removed when removing moisture with an air blower, and if it exceeds the upper limit above, the subsequent drying time becomes longer, resulting in reduced workability and hardening of the tissue. there is.
본 발명의 도두꼬투리로는 도두꼬투리 또는 도두를 이용할 수 있다.As the soybean pods of the present invention, soybean pods or soybean pods can be used.
상기 도두꼬투리는 콩이 안에 들어있는 형태의 콩껍질 전체를 의미하며, 본 발명에서는 미성숙 상태인 것이 바람직하다. 상기 미성숙 상태는, 식약처에서 제공하는 식품 원료 DB에서 정의하고 있는 식품원료 사용가능한 도두꼬투리의 상태로서 어린(연한, 부풀기 전) 상태의 꼬투리를 의미한다. The soybean pod refers to the entire bean shell in which soybean is contained, and in the present invention, it is preferably in an immature state. The immature state refers to the state of pods that can be used as food raw materials defined in the food raw material DB provided by the Ministry of Food and Drug Safety, and refers to pods in a young (soft, before swelling) state.
다음으로, 수분이 제거된 도두를 0.3 내지 5 cm로 절단하고, 50 내지 120℃에서 1 내지 96시간 동안 건조를 수행한다.Next, the soybeans from which moisture has been removed are cut into 0.3 to 5 cm, and dried at 50 to 120 ° C. for 1 to 96 hours.
본 발명은 수분이 포함되어 있는 도두꼬투리를 건조시킴으로써, 도두꼬투리의 껍질이 팽창되도록 하여 건조과정 시 수분의 이동이 촉진되도록 하며 장기 보존이 가능하도록 한다. 만약, 건조과정을 수행하지 않는 경우에는 장기저장이 불가하여 저장 시 미생물의 오염으로 인해 품질이 저하될 수 있다.In the present invention, by drying the pods containing water, the shell of the pods expands to promote the movement of water during the drying process and to enable long-term preservation. If the drying process is not performed, long-term storage is not possible, and the quality may deteriorate due to contamination of microorganisms during storage.
건조 시 온도 및 시간이 상기 하한치 미만인 경우에는 충분히 건조되지 않아 미생물 오염 위험성이 커질 수 있으며, 상기 상한치 초과인 경우에는 도두꼬투리가 탄화되어 벤조피렌이 발생되고 풍미와 같은 품질이 저하될 수 있다.If the temperature and time during drying are less than the lower limit, the risk of microbial contamination may increase due to insufficient drying, and if the temperature and time exceed the upper limit, the soybean pods may be carbonized to generate benzopyrene, and quality such as flavor may deteriorate.
다음으로, 상기 건조된 도두꼬투리 분말에 용매를 첨가한 후 추출공정을 수행한다.Next, an extraction process is performed after adding a solvent to the dried bean pod powder.
상기 용매는 건조된 도두꼬투리 100 중량부에 대하여 500 내지 5,000 중량부, 바람직하게는 1,000 중량부로 첨가된다. 용매의 첨가량이 상기 하한치 미만인 경우에는 추출 수율이 낮아질 수 있으며, 상기 상한치 초과인 경우에는 생산 효율이 낮아지면 이후 단위공정에서 더 많은 시간이 소요될 수 있다. The solvent is added in an amount of 500 to 5,000 parts by weight, preferably 1,000 parts by weight, based on 100 parts by weight of the dried soybean pods. If the amount of the solvent added is less than the lower limit, the extraction yield may be lowered, and if the amount is greater than the upper limit, if the production efficiency is lowered, more time may be required in the subsequent unit process.
추출 시 시간이 상기 하한치 미만인 경우에는 충분히 내용물이 추출되지 않아 수율이 낮아질 수 있으며, 상기 상한치 초과인 경우에는 도두꼬투리가 연화되어 과량의 전분이 용출되어 이후 단위공정에 많은 시간이 소요될 수 있다. If the extraction time is less than the lower limit, the content may not be sufficiently extracted and the yield may be lowered. If the extraction time exceeds the upper limit, the bean pods are softened and excessive starch is eluted, and subsequent unit processes may take a lot of time.
원심공정의 조건은 1,000 내지 10,000 g, 바람직하게는 8000 g로 하며 여과막의 pore size는 0.01 내지 10 ㎛, 바람직하게는 0.45 ㎛ 규격으로 수행한다.The conditions of the centrifugation process are 1,000 to 10,000 g, preferably 8000 g, and the pore size of the filtration membrane is 0.01 to 10 μm, preferably 0.45 μm.
원심분리 및 여과 시 회전 g과 공극 크기가 상기 하한치 미만인 경우에는 전분이 충분히 제거되지 않을 수 있으며, 상기 상한치 초과인 경우에는 공정 효율이 낮아지고 생산 비용의 증대가 초래될 수 있다. If the rotation g and pore size during centrifugation and filtration are less than the lower limit, starch may not be sufficiently removed, and if it exceeds the upper limit, process efficiency may decrease and production cost may increase.
상기 도두꼬투리 추출물은 분무건조, 동결건조, 진공건조, 열풍건조 방법으로 추출분말의 형태로 가공될 수 있다. 상기 추출 분말이란 물에 재수화시 용해성이 우수하며 저장성도 우수하도록 수분함량이 10% 이하인 분말 또는 과립형태로 제조된 것이다. The Dodu pod extract may be processed into an extract powder by spray drying, freeze drying, vacuum drying, or hot air drying. The extract powder is prepared in the form of powder or granules having a water content of 10% or less so as to have excellent solubility when rehydrated in water and excellent storage stability.
또한, 본 발명의 다른 양태에 따르면, 본 발명은 상술한 방법에 따라 제조된, 루틴 함량 및 기능성이 증진된 도두꼬투리 추출물을 제공한다.In addition, according to another aspect of the present invention, the present invention provides a Dodu pod extract with improved rutin content and functionality, prepared according to the above-described method.
또한, 본 발명의 또 다른 양태에 따르면, 본 발명은 상기 도두꼬투리 추출물을 유효성분으로 포함하는 건강기능식품 또는 식품첨가물을 제공한다.In addition, according to another aspect of the present invention, the present invention provides a health functional food or food additive containing the Dodu pod extract as an active ingredient.
본 발명에 따른 제조 방법으로 제조된, 루틴 함량 및 기능성이 증진된 도두꼬투리 추출물은 도두꼬투리 고유의 기능성인 항산화 및 항염증 활성이 증진되었으므로 이를 목적으로 하는 식품첨가물 또는 건강기능식품의 소재로 이용이 가능하다.Dodu pod extract with increased rutin content and functionality, prepared by the manufacturing method according to the present invention, has enhanced antioxidant and anti-inflammatory activity, which is the unique functionality of Dodu pod, so it can be used as a food additive or health functional food material for this purpose. possible.
본 발명에 따른 도두꼬투리 추출물을 건강기능식품 또는 일반 식품의 유효성분 첨가물로 사용하는 경우, 본 발명에 따른 도두꼬투리 추출물을 그대로 첨가하거나 다른 식품 또는 식품성분과 함께 사용할 수 있고, 통상적인 방법에 따라 적절하게 사용할 수 있다. 유효 성분의 혼합양은 예방, 건강 또는 치료 등의 각 사용 목적에 따라 적합하게 결정할 수 있다.When the Dodu pod extract according to the present invention is used as an active ingredient additive for health functional food or general food, the Dodu pod extract according to the present invention can be added as it is or used together with other foods or food ingredients, and can be used according to a conventional method. can be used appropriately. The mixing amount of the active ingredient can be appropriately determined according to each purpose of use, such as prevention, health, or treatment.
일반적으로, 식품 또는 음료의 제조시에 본 발명에 따른 도두꼬투리 추출물은 원료에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양으로 첨가할 수 있다. 그러나, 건강 및 위생을 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있으며, 또한 본 발명은 천연물로부터의 추출물을 이용하는 점에서 안전성 면에서 문제가 없으므로 상기 범위 이상의 양으로도 사용할 수 있다.In general, when preparing food or beverage, the Dodu pod extract according to the present invention may be added in an amount of 15 parts by weight or less, preferably 10 parts by weight or less, based on the raw material. However, in the case of long-term intake for the purpose of health and hygiene or health control, the amount may be less than the above range, and since the present invention uses an extract from a natural product, there is no problem in terms of safety, so the above range The above amount can also be used.
상기 식품의 종류에는 특별히 제한은 없고, 상기 물질을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 쵸콜렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 식품을 모두 포함할 수 있다.The type of food is not particularly limited, and examples of food to which the substance can be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gum, and dairy products including ice cream. , various soups, beverages, tea, drinks, alcoholic beverages and vitamin complexes, etc., and may include all foods in a conventional sense.
본 발명에 따른 건강기능식품 중 음료 식품은 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로 함유할 수 있다. 상술한 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜일 수 있다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명에 따른 기능성 식품 100 mL당 약 0.01 ~ 0.04 g, 바람직하게는 약 0.02 ~ 0.03 g일 수 있다.Among the health functional foods according to the present invention, beverages may contain various flavoring agents or natural carbohydrates as additional ingredients, like conventional beverages. The aforementioned natural carbohydrates may be monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As the sweetener, natural sweeteners such as thaumatin and stevia extract, or synthetic sweeteners such as saccharin and aspartame may be used. The ratio of the natural carbohydrate may be about 0.01 to 0.04 g, preferably about 0.02 to 0.03 g per 100 mL of the functional food according to the present invention.
상기 외 본 발명에 따른 도두꼬투리 추출물을 유효성분으로 포함하는 건강기능식품은 여러가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제를 함유될 수 있으며, 이러한 성분은 독립적으로 또는 혼합하여 사용될 수 있다. 이러한 첨가제의 비율은 제한되지 않으나, 본 발명의 조성물 전체 100 중량부%에 대하여 0.01-0.1 중량부의 범위에서 선택되는 것이 일반적이다.In addition to the above, the health functional food containing the bean pod extract according to the present invention as an active ingredient contains various nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH It may contain regulators, stabilizers, preservatives, glycerin, alcohol, carbonation agents used in carbonated beverages, and these components may be used independently or in combination. The proportion of these additives is not limited, but is generally selected in the range of 0.01-0.1 parts by weight based on 100 parts by weight of the total composition of the present invention.
즉, 본 발명의 도두꼬투리 추출물 또는 추출분말은 건강식품 또는 소스류에 이용될 수 있다. That is, the Dodu pod extract or extract powder of the present invention can be used in health foods or sauces.
상기 건강기능식품이란, 도두꼬투리 추출물을 음료, 차류, 향신료, 껌, 과자류 등의 식품소재에 첨가하거나, 캡슐화, 분말화, 현탁액 등으로 제조한 식품으로, 이를 섭취할 경우 건강상 특정한 효과를 가져오는 것을 의미하나, 일반 약품과는 달리 식품을 원료로 하여 약품의 장기 복용 시 발생할 수 있는 부작용 등이 없는 장점이 있다. 이와 같이 하여 얻어지는 본 발명의 건강기능식품은, 일상적으로 섭취하는 것이 가능하기 때문에 매우 유용하다. 이와 같은 건강기능식품에 있어서의 도두꼬투리 추출물의 첨가량은, 대상인 건강기능식품의 종류에 따라 달라 일률적으로 규정할 수 없지만, 식품 본래의 맛을 손상시키지 않는 범위에서 첨가하면 되며, 대상 식품에 대하여 통상 0.01 내지 50 중량%, 바람직하기로는 0.1 내지 20 중량%의 범위이다. 또한, 환제, 과립제, 정제 또는 캡슐제 형태의 건강기능식품의 경우에는 통상 0.1 내지 100 중량% 바람직하기로는 0.5 내지 80 중량%의 범위에서 첨가하면 된다. 한 구체예에서, 본 발명의 건강기능식품은 환제, 정제, 캡슐제 또는 음료의 형태일 수 있다.The health functional food is a food prepared by adding soybean pod extract to food materials such as beverages, teas, spices, gum, confectionery, etc., or by encapsulation, powdering, suspension, etc., and when ingested, it has a specific effect on health It means coming, but unlike general drugs, it has the advantage of not having side effects that can occur when taking drugs for a long time by using food as a raw material. The health functional food of the present invention obtained in this way is very useful because it can be consumed on a daily basis. The amount of soy bean pod extract added to such health functional foods cannot be uniformly determined depending on the type of target health functional food, but it can be added within a range that does not impair the original taste of the food. It ranges from 0.01 to 50% by weight, preferably from 0.1 to 20% by weight. In addition, in the case of health functional foods in the form of pills, granules, tablets or capsules, it is usually added in the range of 0.1 to 100% by weight, preferably 0.5 to 80% by weight. In one embodiment, the health functional food of the present invention may be in the form of pills, tablets, capsules or beverages.
또한, 상기 소스류로는 콩소스, 드레싱 소스, 된장 소스 등을 들 수 있다.In addition, the sauces may include soybean sauce, dressing sauce, soybean paste sauce, and the like.
또한, 본 발명의 또 다른 양태에 따르면, 본 발명은 상기 루틴 함량 및 기능성이 증진된 도두꼬투리 추출물을 유효성분으로 포함하는 항산화 또는 항염증용 화장료 조성물을 제공한다.In addition, according to another aspect of the present invention, the present invention provides a cosmetic composition for anti-oxidation or anti-inflammatory, comprising the extract of Dodu pod with enhanced rutin content and functionality as an active ingredient.
본 발명에 따른 제조 방법으로 제조된 도두꼬투리 추출물은 고유 기능이 보존되므로 이를 목적으로 하는 화장료의 소재로 이용이 가능하다.The Dodu pod extract prepared by the manufacturing method according to the present invention can be used as a cosmetic material for this purpose because the unique function is preserved.
본 조성물 내 추출물은 전체 중량비에서 1 내지 30 중량%로 함유될 수 있으며, 5 내지 20 중량%로 함유될 수 있다.The extract in the present composition may be contained in an amount of 1 to 30% by weight, and may be contained in an amount of 5 to 20% by weight in the total weight ratio.
또한, 본 발명의 도두꼬투리 추출물을 포함하는 화장료 조성물은 상기 추출물 이외에 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제 및 담체를 포함할 수 있으며, 담체와 함께 제형화할 수 있다. 본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양 크림, 맛사지 크림, 에센스, 아이크림, 헤어토닉, 샴푸, 린스, 클렌징 크림, 클렌징포옴, 클렌징워터, 팩, 스프레이 및 파우더의 제형으로 제조될 수 있다.In addition, the cosmetic composition containing the extract of Dodu pods of the present invention may include conventional adjuvants and carriers such as antioxidants, stabilizers, solubilizers, vitamins, pigments, and flavors in addition to the extract, and may be formulated with a carrier. there is. The cosmetic composition of the present invention can be prepared in any formulation conventionally prepared in the art, for example, a solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing , It may be formulated as an oil, powder foundation, emulsion foundation, wax foundation and spray, but is not limited thereto. More specifically, it can be prepared in formulations of flexible lotion, nutrient lotion, nutrient cream, massage cream, essence, eye cream, hair tonic, shampoo, rinse, cleansing cream, cleansing foam, cleansing water, pack, spray, and powder. .
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as a carrier component. can
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, additional chlorofluorohydrocarbon, propane / May contain a propellant such as butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solubilizing agent or emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 ,3-butyl glycol, glycerol aliphatic esters, polyethylene glycol or fatty acid esters of sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁화제, 미소 결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystals Star cellulose, aluminum metahydroxide, bentonite, agar or tracanth and the like may be used.
본 발명의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is surfactant-containing cleansing, as carrier components, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide Ether sulfates, alkylamidobetaines, fatty alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives, or ethoxylated glycerol fatty acid esters may be used.
본 발명의 화장료 조성물은 상술한 루틴 함량 및 기능성이 증진된 도두꼬투리 추출물을 포함하므로, 중복된 내용은 본 명세서의 과도한 복잡성을 피하기 위하여 그 기재를 생략한다.Since the cosmetic composition of the present invention includes the above-described Dodu pod extract with enhanced rutin content and functionality, duplicate descriptions are omitted to avoid excessive complexity in the present specification.
또한, 본 발명의 또 다른 양태에 따르면, 본 발명은 상술한 루틴 함량 및 기능성이 증진된 도두꼬투리 추출물을 유효성분으로 포함하는 항산화 및 항염증용 약학적 조성물을 제공한다.In addition, according to another aspect of the present invention, the present invention provides a pharmaceutical composition for antioxidant and anti-inflammatory containing the above-described Dodu pod extract with enhanced rutin content and functionality as an active ingredient.
본 발명의 구체적인 일 실시예에서, 본 발명자들은 루틴 함량 및 기능성이 증진된 도두꼬투리 추출물의 세포 독성 여부를 확인하기 위해 대식세포 생존률을 분석한 결과, 세포 독성이 없는 것을 확인하였다. 또한, 본 발명자들은 루틴 함량 및 기능성이 증진된 도두꼬투리 추출물의 항산화 효과를 확인하기 위하여 ABTS 소거, DPPH 소거 및 총 폴리페놀 함량을 분석한 결과, 증대된 항산화 활성 효과를 나타냄을 확인하였다. 또한, 본 발명자들은 루틴 함량 및 기능성이 증진된 도두꼬투리 추출물의 항염증 효과를 확인하기 위하여 산화질소(NO) 생성량을 분석한 결과, 높은 산화질소 생성 억제 효과를 나타냄을 확인하였다. In a specific embodiment of the present invention, the present inventors analyzed the viability of macrophages in order to determine whether the Dodu pod extract with increased rutin content and functionality was cytotoxic, and as a result, it was confirmed that there was no cytotoxicity. In addition, the present inventors analyzed ABTS elimination, DPPH elimination, and total polyphenol content in order to confirm the antioxidant effect of the Dodu pod extract with enhanced rutin content and functionality, and as a result, it was confirmed that it exhibited increased antioxidant activity. In addition, the present inventors analyzed the amount of nitric oxide (NO) produced in order to confirm the anti-inflammatory effect of the rutin content and functionality of the Dodu pod extract, and as a result, it was confirmed that it exhibited a high nitric oxide production inhibitory effect.
따라서, 본 발명의 루틴 함량 및 기능성이 증진된 도두꼬투리 추출물은 항산화 및 항염증용 약학적 조성물로서 염증 질환의 예방 또는 치료용 약학적 조성물로 유용하게 사용될 수 있다.Therefore, the extract of the Dodu pod with enhanced rutin content and functionality of the present invention can be usefully used as a pharmaceutical composition for preventing or treating inflammatory diseases as a pharmaceutical composition for antioxidant and anti-inflammatory.
상기 염증 질환은 염증성 장질환, 사구체신염, 염증성 피부 질환, 망막염, 위염, 간염, 장염, 관절염, 편도선염, 인후염, 기관지염, 폐렴, 췌장염 및 신장염으로 이루어진 군 중에서 선택되는 것일 수 있다.The inflammatory disease may be selected from the group consisting of inflammatory bowel disease, glomerulonephritis, inflammatory skin disease, retinitis, gastritis, hepatitis, enteritis, arthritis, tonsillitis, sore throat, bronchitis, pneumonia, pancreatitis and nephritis.
본 발명에 따른 약학적 조성물은 상기 본 발명의 추출물을 단독으로 함유하거나 또는 하나 이상의 약학적으로 허용되는 담체, 부형제 또는 희석제를 추가로 함유할 수 있다. 상기에서 "약학적으로 허용되는" 이란 생리학적으로 허용되고 인간에게 투여될 때, 활성성분의 작용을 저해하지 않으며 통상적으로 위장 장애, 현기증과 같은 알레르기 반응 또는 이와 유사한 반응을 일으키지 않는 비독성의 조성물을 말한다.The pharmaceutical composition according to the present invention may contain the extract of the present invention alone or may further contain one or more pharmaceutically acceptable carriers, excipients or diluents. In the above, "pharmaceutically acceptable" is a non-toxic composition that is physiologically acceptable and does not inhibit the action of the active ingredient when administered to humans and does not usually cause allergic reactions such as gastrointestinal disorders and dizziness or similar reactions. says
약학적으로 허용되는 담체로는 예컨대, 경구 투여용 담체 또는 비경구 투여용 담체를 추가로 포함할 수 있다.A pharmaceutically acceptable carrier may further include, for example, a carrier for oral administration or a carrier for parenteral administration.
경구 투여용 담체는 락토스, 전분, 셀룰로스 유도체, 마그네슘 스테아레이트, 스테아르산 등을 포함할 수 있다.Carriers for oral administration may include lactose, starch, cellulose derivatives, magnesium stearate, stearic acid and the like.
또한, 비경구 투여용 담체는 물, 적합한 오일, 식염수, 수성 글루코오스 및 글리콜 등을 포함할 수 있으며, 안정화제 및 보존제를 추가로 포함할 수 있다. 적합한 안정화제로는 아황산수소나트륨, 아황산나트륨 또는 아스코르브산과 같은 항산화제가 있다. 적합한 보존제로는 벤즈알코늄 클로라이드, 메틸- 또는 프로필-파라벤 및 클로로부탄올이 있다. 본 발명의 약학적 조성물은 상기 성분들 이외에 윤활제, 습윤제, 감미제, 향미제, 유화제, 현택제 등을 추가로 포함할 수 있다. 그 밖의 약학적으로 허용되는 담체 및 제제는 다음의 문헌에 기재되어 있는 것을 참고로 할 수 있다(Remington's Pharmaceutical Sciences, 19th ed., Mack Publishing Company, Easton, PA, 1995).In addition, the carrier for parenteral administration may include water, suitable oil, saline, aqueous glucose and glycol, and the like, and may further include a stabilizer and a preservative. Suitable stabilizers include antioxidants such as sodium bisulfite, sodium sulfite or ascorbic acid. Suitable preservatives include benzalkonium chloride, methyl- or propyl-paraben and chlorobutanol. The pharmaceutical composition of the present invention may further include a lubricant, a wetting agent, a sweetening agent, a flavoring agent, an emulsifier, a suspending agent, and the like in addition to the above components. Other pharmaceutically acceptable carriers and formulations may be referenced as described in the following literature (Remington's Pharmaceutical Sciences, 19th ed., Mack Publishing Company, Easton, PA, 1995).
본 발명의 조성물은 인간을 비롯한 포유동물에 어떠한 방법으로도 투여할 수 있다. 예를 들면, 경구 또는 비경구적으로 투여할 수 있다. 비경구적인 투여방법으로는 이에 한정되지는 않으나, 정맥내, 근육내, 동맥내, 골수내, 경막내, 심장내, 경피, 피하, 복강내, 비강내, 장관, 국소, 설하 또는 직장내 투여일 수 있다.The composition of the present invention can be administered to mammals including humans by any method. For example, it can be administered orally or parenterally. Parenteral administration methods include, but are not limited to, intravenous, intramuscular, intraarterial, intramedullary, intrathecal, intracardiac, transdermal, subcutaneous, intraperitoneal, intranasal, intestinal, topical, sublingual or rectal administration can be
본 발명의 약학적 조성물은 상술한 바와 같은 투여 경로에 따라 경구 투여용 또는 비경구 투여용 제제로 제형화할 수 있다. 경구 투여용 제제의 경우에 본 발명의 조성물은 분말, 과립, 정제, 환제, 당의정제, 캡슐제, 액제, 겔제, 시럽제, 슬러리제, 현탁액 등으로 당업계에 공지된 방법을 이용하여 제형화될 수 있다. 예를 들어, 경구용 제제는 활성성분을 고체 부형제와 배합한 다음 이를 분쇄하고 적합한 보조제를 첨가한 후 과립 혼합물로 가공함으로써 정제 또는 당의정제를 수득할 수 있다. 적합한 부형제의 예로는 락토즈, 덱스트로즈, 수크로즈, 솔비톨, 만니톨, 자일리톨, 에리스리톨 및 말티톨 등을 포함하는 당류와 옥수수 전분, 밀 전분, 쌀 전분 및 감자전분 등을 포함하는 전분류, 셀룰로즈,메틸 셀룰로즈, 나트륨 카르복시메틸셀룰로오즈 및 하이드록시프로필메틸-셀룰로즈 등을 포함하는 셀룰로즈류, 젤라틴, 폴리비닐피롤리돈 등과 같은 충전제가 포함될 수 있다. 또한, 경우에 따라 가교결합 폴리비닐피롤리돈, 한천, 알긴산 또는 나트륨 알기네이트 등을 붕해제로 첨가할 수 있다. 나아가, 본 발명의 약학적 조성물은 항응집제, 윤활제, 습윤제, 향료, 유화제 및 방부제 등을 추가로 포함할 수 있다.The pharmaceutical composition of the present invention may be formulated into a formulation for oral administration or parenteral administration according to the administration route as described above. In the case of preparations for oral administration, the composition of the present invention may be formulated into powders, granules, tablets, pills, dragees, capsules, solutions, gels, syrups, slurries, suspensions, etc. using a method known in the art. can For example, preparations for oral use may be obtained by combining the active ingredient with a solid excipient, which is then milled and, after adding suitable auxiliaries, processed into a mixture of granules to obtain tablets or dragees. Examples of suitable excipients include sugars including lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol and maltitol, starches including corn starch, wheat starch, rice starch and potato starch, cellulose, Celluloses including methyl cellulose, sodium carboxymethylcellulose and hydroxypropylmethyl-cellulose, and the like, fillers such as gelatin, polyvinylpyrrolidone, and the like may be included. In addition, cross-linked polyvinylpyrrolidone, agar, alginic acid or sodium alginate may be added as a disintegrant, if desired. Furthermore, the pharmaceutical composition of the present invention may further include an anticoagulant, a lubricant, a wetting agent, a flavoring agent, an emulsifier, and a preservative.
비경구 투여용 제제의 경우에는 주사제, 크림제, 로션제, 외용연고제, 오일제, 보습제, 겔제, 에어로졸 및 비강 흡입제의 형태로 당업계에 공지된 방법으로 제형화할 수 있다. In the case of preparations for parenteral administration, they may be formulated in the form of injections, creams, lotions, external ointments, oils, moisturizers, gels, aerosols, and nasal inhalants by methods known in the art.
본 발명의 조성물의 총 유효량은 단일 투여량(single dose)으로 환자에게 투여될 수 있으며, 다중 투여량(multiple dose)으로 장기간 투여되는 분할 치료 방법(fractionated treatment protocol)에 의해 투여될 수 있다. 본 발명의 약학적 조성물은 질환의 정도에 따라 유효성분의 함량을 달리할 수 있다. 바람직하게 본 발명의 약학적 조성물의 바람직한 전체 용량은 1일당 환자 체중 1㎏ 당 약 0.01㎍ 내지 1,000mg, 가장 바람직하게는 0.1㎍ 내지 500mg일 수 있다. 그러나 상기 약학적 조성물의 용량은 제제화 방법, 투여 경로 및 치료 횟수뿐만 아니라 환자의 연령, 체중, 건강 상태, 성별, 질환의 중증도, 식이 및 배설율등 다양한 요인들을 고려하여 환자에 대한 유효 투여량이 결정되는 것이므로, 이러한 점을 고려할 때 당 분야의 통상적인 지식을 가진 자라면 본 발명의 조성물의 적절한 유효 투여량을 결정할 수 있을 것이다. 본 발명에 따른 약학적 조성물은 본 발명의 효과를 보이는 한 그 제형, 투여 경로 및 투여 방법에 특별히 제한되지 않는다. The total effective amount of the composition of the present invention can be administered to the patient in a single dose or by a fractionated treatment protocol in which multiple doses are administered over a long period of time. The pharmaceutical composition of the present invention may vary the content of the active ingredient according to the severity of the disease. Preferably, the preferred total dose of the pharmaceutical composition of the present invention may be about 0.01 μg to 1,000 mg, most preferably 0.1 μg to 500 mg per kg of patient body weight per day. However, the dose of the pharmaceutical composition is determined by considering various factors such as the formulation method, administration route, and number of treatments as well as the patient's age, weight, health condition, sex, severity of disease, diet, and excretion rate. Therefore, considering this point, those skilled in the art will be able to determine an appropriate effective dosage of the composition of the present invention. The pharmaceutical composition according to the present invention is not particularly limited in its formulation, administration route and administration method as long as it exhibits the effects of the present invention.
본 발명의 약학적 조성물은 상술한 루틴 함량 및 기능성이 증진된 도두꼬투리 추출물을 포함하므로, 중복된 내용은 본 명세서의 과도한 복잡성을 피하기 위하여 그 기재를 생략한다.Since the pharmaceutical composition of the present invention includes the above-described Dodu pod extract with enhanced rutin content and functionality, duplicate descriptions are omitted to avoid excessive complexity in the present specification.
또한, 본 발명의 또 다른 양태에 따르면, 본 발명은 상기 도두꼬투리 추출물을 유효성분으로 포함하는 항산화 및 항염증용 사료 첨가제를 제공한다.In addition, according to another aspect of the present invention, the present invention provides a feed additive for antioxidant and anti-inflammatory comprising the extract of the Dodu pod as an active ingredient.
본 발명의 상기 사료 첨가제는 상술한 본 발명의 도두꼬투리 추출물을 유효성분으로 포함하여, 안전하므로 이를 사료 첨가제로 사용할 경우 목적 대상 동물의 품질 증강에 기여할 수 있다.The feed additive of the present invention contains the above-mentioned Dodu pod extract of the present invention as an active ingredient and is safe, so when used as a feed additive, it can contribute to improving the quality of the target animal.
본 발명의 상기 사료 첨가제는 상술한 도두꼬투리 추출물을 원형 그대로 사용하거나 또는 추가적으로 목적 대상 동물에 허용되는 곡류 및 그 부산물 등의 공지된 담체, 안정제 등을 가할 수 있으며, 필요에 따라 구연산, 후말산, 아디픽산, 젖산, 사과산 등의 유기산이나 인산나트륨, 인산칼륨, 산성 피로인산염, 폴리인산염(중합인산염) 등의 인산염이나, 폴리페놀, 카테킨, 알파-토코페롤, 로즈마리 추출물, 비타민 C, 녹차 추출물, 감초 추출물, 키토산, 탄닌산, 피틴산 등의 천연 항산화제, 항생물질, 항균제 및 기타의 첨가제 등을 가할 수도 있으며, 그 형상으로서는 분체, 과립, 펠릿, 현탁액 등의 적당한 상태일 수 있으며, 상기 사료첨가제를 공급하는 경우는 도두꼬투리 추출물에 대하여 단독으로 또는 사료에 혼합하여 공급할 수 있다.For the feed additive of the present invention, the above-described Dodu pod extract may be used as it is or additionally known carriers such as grains and their by-products acceptable for the target animal, stabilizers, etc. may be added, and, if necessary, citric acid, fumalic acid, Organic acids such as adipic acid, lactic acid, and malic acid; phosphates such as sodium phosphate, potassium phosphate, acidic pyrophosphate, polyphosphate (polyphosphate), polyphenol, catechin, alpha-tocopherol, rosemary extract, vitamin C, green tea extract, licorice Extracts, natural antioxidants such as chitosan, tannic acid, and phytic acid, antibiotics, antibacterial agents, and other additives may be added, and the form may be in a suitable state such as powder, granule, pellet, or suspension. In the case of use, the extract of the bean pod can be supplied alone or mixed with feed.
본 발명의 사료 첨가제는 상술한 루틴 함량 및 기능성이 증진된 도두꼬투리 추출물을 포함하므로, 중복된 내용은 본 명세서의 과도한 복잡성을 피하기 위하여 그 기재를 생략한다.Since the feed additive of the present invention includes the above-described Dodu pod extract with enhanced rutin content and functionality, duplicate descriptions are omitted to avoid excessive complexity in the present specification.
본 발명은 루틴 함량 및 기능성이 증대된 도두꼬투리 추출물 제조 방법 및 이에 따라 제조된 추출물에 관한 것으로, 본 발명의 방법에 따라 제조된 루틴 함량 및 기능성이 증대된 도두꼬투리 추출물은 우수한 ABTS 소거, DPPH 소거 및 총 폴리페놀 함량 증대 효과와, 우수한 산화질소 생성 억제 효과를 나타내므로, 항산화 및 항염증 조성물로 유용하게 사용할 수 있다. The present invention relates to a method for preparing a Dodu pod extract with increased rutin content and functionality and an extract prepared thereby, wherein the Dodu pod extract with increased rutin content and functionality prepared according to the method of the present invention has excellent ABTS scavenging and DPPH scavenging And since it shows an effect of increasing the total polyphenol content and an excellent nitric oxide production inhibitory effect, it can be usefully used as an antioxidant and anti-inflammatory composition.
도 1은 본 발명에 사용된 도두꼬투리 및 도두 원료의 특징을 나타낸 사진이다.
도 2a는 280 nm에서 HPLC-UV vis 크로마토그램 HPLC를 보여주고, 도 2b는 이에 의한 루틴 함량 측정 결과를 보여준다. 데이터는 평균 ± SD(n=3)로 표시된다.
도 3a는 ABTS 라디칼 소거 활성에 대한 ISBP 추출물의 효과를 보여주고, 도 3b는 DPPH 라디칼 소거 활성에 대한 ISBP 추출물의 효과를 보여주고, 도 3c는 총 폴리페놀 함량에 대한 ISBP 추출물의 효과를 보여주고, 도 4d는 총 플라보노이드 함량에 대한 ISBP 추출물의 효과를 보여준다. VC, 비타민 C; GA, 갈산. 데이터는 평균 ± SD(n=5)로 표시된다.
도 4a는 LPS-유도 RAW264.7 세포주에서의 세포 생존율에 대한 ISBP 추출물의 효과를 보여주고, 도 4b는 산화질소(NO) 수준에 대한 ISBP 추출물의 효과를 보여준다. 값은 평균 ± SD(n=6)이다. * p<0.05 vs NC.1 is a photograph showing the characteristics of soybean pods and soybean raw materials used in the present invention.
Figure 2a shows the HPLC-UV vis chromatogram HPLC at 280 nm, and Figure 2b shows the result of measuring the rutin content. Data are presented as mean ± SD (n = 3).
Figure 3a shows the effect of ISBP extract on ABTS radical scavenging activity, Figure 3b shows the effect of ISBP extract on DPPH radical scavenging activity, Figure 3c shows the effect of ISBP extract on total polyphenol content, , Figure 4d shows the effect of ISBP extract on total flavonoid content. VC, vitamin C; GA, gallic acid. Data are presented as mean ± SD (n = 5).
Figure 4a shows the effect of ISBP extract on cell viability in the LPS-induced RAW264.7 cell line, and Figure 4b shows the effect of ISBP extract on nitric oxide (NO) levels. Values are mean ± SD (n = 6). * p < 0.05 vs NC.
이하, 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로서, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the examples are only for explaining the present invention in more detail, and those skilled in the art that the scope of the present invention is not limited by these examples according to the gist of the present invention It will be self-evident for
실험 방법Experiment method
실험재료experimental material
본 실시예에서 사용한 도두꼬투리는 전라남도 화순군에서 2021년에 재배하여 수확한 것을 열풍건조한 후 분쇄하여 사용하였다.The bean pods used in this example were grown and harvested in Hwasun-gun, Jeollanam-do in 2021, dried with hot air, and then pulverized and used.
시약reagent
실험에 사용된 DPPH, ABTS, L-ascorbic acid, Folin-Ciocalteu's phenol reagent, gallic acid, Rutin 은 Sigma Chemical Co.(USA)에서 구입하였다.DPPH, ABTS, L-ascorbic acid, Folin-Ciocalteu's phenol reagent, gallic acid, and Rutin used in the experiment were purchased from Sigma Chemical Co. (USA).
추출물 제조extract manufacturing
도두꼬투리는 55±1℃에서 2일간 열풍 건조하고 분쇄한 후 -20℃에 보관하면서 사용하였다. 건조하여 분쇄한 시료 100 g에 각각 1000 mL, 100℃ 열수 및 1000 mL 상온에서 30%, 50% 발효주정 (I1-San Trading Co., Ltd., Haman, Korea)으로 24 시간 동안 추출하였다. 추출 후 8000 g, 20분간 원심분리한 후 상등액을 0.45 μm membrane filter로 여과하여 추출물을 제조하였다. 해당 추출물은 감압농축기로 농축하여 제조하였다.The soybean pods were dried with hot air at 55 ± 1 ° C for 2 days, ground, and stored at -20 ° C. 100 g of dried and pulverized samples were extracted with 30% and 50% fermented alcohol (I1-San Trading Co., Ltd., Haman, Korea) at 1000 mL, 100 ° C hot water and 1000 mL room temperature, respectively, for 24 hours. After extraction, centrifugation was performed at 8000 g for 20 minutes, and the supernatant was filtered through a 0.45 μm membrane filter to prepare an extract. The extract was prepared by concentrating with a vacuum concentrator.
pH 및 가용성고형분 함량 측정Measurement of pH and soluble solids content
pH 측정은 pH meter(Orion Star A211 pH benchtop meter; Thermo Scientific?; Waltham, MA, USA)를 사용하였고 당도 측정은 굴절당도계(Sccharometer, W.S.R.O-90, Atago, Co., Tokyo, Japan)를 사용하였다A pH meter (Orion Star A211 pH benchtop meter; Thermo Scientific?; Waltham, MA, USA) was used to measure pH, and a refractometer (Sccharometer, W.S.R.O-90, Atago, Co., Tokyo, Japan) was used to measure sugar content.
DPPH assayDPPH assay
도두꼬투리 열수 및 주정 추출물의 DPPH 라디칼 소거능은 Blois MS(1958)의 방법을 이용하여 측정하였다. 농도별 시료 1mL에 75 nM DPPH 용액 2 mL를 혼합하고, 37℃에서 30분간 방치한 후 517 nm에서 UV/visible spectrophotometer를 이용하여 흡광도를 측정하였다. 대조군으로 L-ascorbic acid를 사용하였고, DPPH 라디칼 소거 활성은 Standard의 흡광도에 대한 농도의 Standard curve를 구한 뒤 Sample의 Antioxidant capacity를 구한다.The DPPH radical scavenging ability of hot water and alcohol extracts from Dodu pods was measured using the method of Blois MS (1958). 2 mL of 75 nM DPPH solution was mixed with 1 mL of each concentration sample, left at 37 ° C for 30 minutes, and then absorbance was measured at 517 nm using a UV / visible spectrophotometer. L-ascorbic acid was used as a control, and the DPPH radical scavenging activity was obtained by obtaining the standard curve of the concentration against the absorbance of the standard, and then obtaining the antioxidant capacity of the sample.
Antioxidant capacity (%) = 100-100*{(sample 의 O.D-blank O.D)/(control의 O.D-blank의 O.D}Antioxidant capacity (%) = 100-100*{(O.D-blank O.D of sample)/(O.D of O.D-blank of control}
ABTS assayABTS assay
도두꼬투리 열수 및 주정 추출물의 ABTS 라디칼 소거능을 통한 항산화 활성 평가는 Re R 등(1999)의 방법을 이용하여 측정하였다. 70℃ 수조에서 1.0 mM AAPH (2,2'-azobis-(2-amidinopropane)HCl)와 2.5 mM ABTS2- (2,2'-azino-bis (3-ethyl benzthiazoline-6-sulfonic acid) diammonium salt)을 100ml의 PBS에 용해 한 후 ABTS solution이 0.65정도의 흡광도를 나타낼 때까지 734nm에서 희석한다. solution을 filtering 시킨 후, 37℃에서 측정한다. 20 mL의 Sample과 980 mL의 ABTS solution을 10분간 반응시키면서 흡광도를 측정한 후 antioxidant capacity를 측정한다. 7 mM ABTS와 2.45 mM potassium persulfate를 1:1로 혼합하여 12시간 동안 30℃의 암소에서 방치한 후 5 mM potassium phosphate buffer(pH 7.4)를 이용하여 413 nm에서 흡광도가 0.7이 되도록 희석하였다. 희석한 ABTS 시약 4 mL에 농도별로 제조한 시료 40 μL를 혼합하여 1분 동안 반응시킨 후 413 nm에서 흡광도를 측정하였다. Standard의 흡광도에 대한 농도의 Standard curve를 구한 뒤 Sample의 Antioxidant capacity를 구한다.The evaluation of antioxidant activity through the ABTS radical scavenging ability of hot water and alcohol extracts from Dodu pods was measured using the method of Re R et al. (1999). 1.0 mM AAPH (2,2'-azobis-(2-amidinopropane)HCl) and 2.5 mM ABTS2-(2,2'-azino-bis (3-ethyl benzthiazoline-6-sulfonic acid) diammonium salt) in a water bath at 70 °C. After dissolving in 100ml of PBS, dilute at 734nm until the ABTS solution shows an absorbance of about 0.65. After filtering the solution, it is measured at 37℃. After measuring absorbance while reacting 20 mL of sample with 980 mL of ABTS solution for 10 minutes, antioxidant capacity is measured. After mixing 7 mM ABTS and 2.45 mM potassium persulfate at a ratio of 1:1 and leaving it in the dark at 30° C. for 12 hours, absorbance at 413 nm was diluted to 0.7 using 5 mM potassium phosphate buffer (pH 7.4). 40 μL of the sample prepared for each concentration was mixed with 4 mL of diluted ABTS reagent, reacted for 1 minute, and absorbance was measured at 413 nm. After obtaining the standard curve of the concentration against the absorbance of the standard, the antioxidant capacity of the sample is obtained.
Antioxidant capacity(%) = 100-100*{(sample 의 O.D-blank O.D)/(control의 O.D-blank의 O.D}Antioxidant capacity (%) = 100-100*{(O.D-blank O.D of sample)/(O.D of O.D-blank of control}
총 phenolic compound 및 flavonoids 함량Total phenolic compound and flavonoids content
총 phenolics 함량은 Folin과 Denis [21]의 방법을 조금 변형하여 실시하였다. 희석한 시료(50배 희석) 추출물과 25% Na2CO3 용액을 각각 0.5 mL씩 시험관에 분주하여 3분간 반응한 후 0.2N Folin-Ciocalteu phenol 시약 0.25 mL 첨가하여 3분간 발색 시켰다. 이 후 원심분리하여 상등액을 720 nm에서 측정하였고 함량은 gallic acid를 이용하여 작성된 표준 검량곡선에 대입하여 값을 계산하였다. The total phenolics content was determined using the method of Folin and Denis [21] with minor modifications. 0.5 mL each of the diluted sample (50-fold dilution) extract and 25% Na2CO3 solution was dispensed into a test tube, reacted for 3 minutes, and then 0.25 mL of 0.2N Folin-Ciocalteu phenol reagent was added to develop color for 3 minutes. After centrifugation, the supernatant was measured at 720 nm, and the content was calculated by substituting it into a standard calibration curve prepared using gallic acid.
총 flavonoids 함량은 Lee 등 [22]의 방법을 약간 변형하여 실시하였다. 희석된 시료(20배 희석) 추출물 0.5 mL를 시험관에 분주하고 diethylene glycol 용액 1 mL과 1 N NaOH 0.01 mL 를 혼합하여 항온수조(37℃)에서 1시간 반응시킨 후 420 nm로 측정하였으며 rutin을 이용하여 작성된 표준 검량곡선으로부터 함량을 계산하였다. The total flavonoids content was determined by slightly modifying the method of Lee et al. [22]. 0.5 mL of the diluted sample (20-fold dilution) was dispensed into a test tube, mixed with 1 mL of diethylene glycol solution and 0.01 mL of 1 N NaOH, reacted in a constant temperature water bath (37 ° C) for 1 hour, and then measured at 420 nm using rutin. The content was calculated from the standard calibration curve prepared by
Rutin 함량 측정Rutin content measurement
농축액 시료를 0.45 μm membrane filter로 여과하여 분석시료로 사용하였다. 시료 주입량은 10 μL, 유속은 0.8 mL/min을 유지하였고 HPLC 칼럼은 SHISEIDO (4.6Х250 nm, 5 μm, SHISEIDO, Tokyo, Japan)를 사용하였으며 280 nm 파장에서 분석을 진행하였다. 이동상 용매는 HPLC water (0.1% Acetic acid)와 HPLC acetonitrile를 각각 용매 A와 용매 B로 사용하였으며 분석조건은 용매 B를 기준으로 16 min-16%, 18 min-100%, 22 min-100%, 25 min-16%, 30 min-16% 로 분석하였다.The concentrated liquid sample was filtered through a 0.45 μm membrane filter and used as an analysis sample. The sample injection amount was 10 μL and the flow rate was 0.8 mL/min. SHISEIDO (4.6Х250 nm, 5 μm, SHISEIDO, Tokyo, Japan) was used as the HPLC column, and analysis was performed at a wavelength of 280 nm. As the mobile phase solvent, HPLC water (0.1% acetic acid) and HPLC acetonitrile were used as solvent A and solvent B, respectively, and the analysis conditions were 16 min-16%, 18 min-100%, 22 min-100%, 25 min-16%, 30 min-16% were analyzed.
실시예 1. ISBP(Immature Sword Bean Pod) 내 지표 물질 선별Example 1. Selection of indicator substances in ISBP (Immature Sword Bean Pod)
본 발명자들은 도두꼬투리(ISBP, Immature Sword Bean Pod)의 건강기능식품으로의 개발을 위해 원료 표준화에서 가장 중요한 지표 물질을 선별하고자 125종의 플라보노이드 및 페놀계 화합물에 대한 성분 조사를 진행하여 하기 표 1에 정렬하였다.In order to select the most important indicator substance in raw material standardization for the development of ISBP (Immature Sword Bean Pod) as a health functional food, the present inventors conducted a component investigation on 125 kinds of flavonoids and phenolic compounds, and Table 1 below sorted on.
[표 1] [Table 1]
그 결과, 콩에서는 분석되지 않으나, 꼬투리에서만 특이적으로 검출되며, 가장 높은 안정성을 가지고, 도두꼬투리 내 성분 함량이 많으며, 하기 화학식 1을 갖는, 루틴(rutin)을 지표 화합물(indicator compound)로서 선별하였다.As a result, rutin, which was not analyzed in soybeans but was specifically detected only in pods, has the highest stability, has a high component content in soybean pods, and has the following
[화학식 1][Formula 1]
실시예 2. 도두꼬투리의 추출 조건에 따른 루틴 함량 확인Example 2. Confirmation of rutin content according to extraction conditions of soybean pods
본 발명자들은 상기 실시예 1에서 선별된 지표 화합물인 루틴의 함량을 증진시킬 수 있는 조건을 확립하고자, ISBP를 하기 표 2와 같은 다양한 추출 조건(열수추출, 주정 농도 30% 및 50%)으로 추출한 후, HPLC UV-vis를 통해 루틴 함량을 검출하였다.In order to establish conditions capable of increasing the content of rutin, the indicator compound selected in Example 1, the present inventors extracted ISBP under various extraction conditions (hot water extraction, alcohol concentration of 30% and 50%) as shown in Table 2 below. After that, the rutin content was detected through HPLC UV-vis.
[표 2][Table 2]
그 결과, 도 2a 및 2b에 나타낸 바와 같이, 도두꼬투리의 추출 용매로 30% 발효주정(에탄올)을 이용하여 추출했을 때 루틴의 함량이 유의하게 가장 높았으며, 이는 열수 추출물보다 약 3배나 더 현저하게 높은 것으로 나타났다.As a result, as shown in FIGS. 2a and 2b, the content of rutin was significantly higher when 30% fermented alcohol (ethanol) was used as an extraction solvent for the bean pods, which was about 3 times more significant than that of the hot water extract. appeared to be high.
실시예 3. 도두꼬투리의 추출 조건에 따른 항산화 확인Example 3. Confirmation of antioxidant according to extraction conditions of soybean pods
본 발명자들은 기능성 효능으로서 항산화를 증진시킬 수 있는 조건을 확립하고자, ISBP를 상기 표 2와 같은 다양한 추출 조건으로 추출한 후, ABTS 소거, DPPH 소거, 총 폴리페놀 함량 및 총 플라보노이드 함량 수준을 각각 확인하였다.In order to establish conditions capable of enhancing antioxidant as a functional effect, the present inventors extracted ISBP under various extraction conditions as shown in Table 2, and then confirmed the levels of ABTS elimination, DPPH elimination, total polyphenol content and total flavonoid content, respectively. .
그 결과, 도 3a 내지 3d에 나타낸 바와 같이, 도두꼬투리의 추출 용매로 30% 발효주정(에탄올)을 이용하여 추출했을 때 항산화능(ABTS, DPPH 소거), 폴리페놀 함량, 플라보노이드 함량이 유의하게 가장 높은 것으로 나타났다.As a result, as shown in Figures 3a to 3d, when extracting pods using 30% fermented alcohol (ethanol) as an extraction solvent, the antioxidant activity (ABTS, DPPH scavenging), polyphenol content, and flavonoid content were significantly the highest. appeared to be high.
실시예 4. 도두꼬투리의 추출 조건에 따른 세포독성 및 항염증 확인Example 4. Confirmation of cytotoxicity and anti-inflammation according to extraction conditions of soybean pods
본 발명자들은 기능성 효능으로서 세포생존율을 증진시킬 수 있는 조건을 확립하고자, ISBP를 상기 표 2와 같은 다양한 추출 조건으로 추출한 후, RAW 264.7 세포주에서의 세포독성 및 항염증에 미치는 영향을 각각 확인하였다.The present inventors, in order to establish conditions capable of enhancing cell viability as functional efficacy, extracted ISBP under various extraction conditions as shown in Table 2 above, and then confirmed the effects on cytotoxicity and anti-inflammatory in the RAW 264.7 cell line, respectively.
그 결과, 도 4a에 나타낸 바와 같이, 추출물 모두 세포 독성을 나타내지 않았다.As a result, as shown in Figure 4a, none of the extracts showed cytotoxicity.
또한, 그 결과, 도 4b에 나타낸 바와 같이, RAW 264.7 세포주에 LPS(lipopolysaccharide)로 염증을 유도한 후 산화질소(NO) 수준을 확인했을 때, 모든 ISBP 추출물이 NO 생성을 용량 의존적으로 감소시키는 것을 확인하였다.In addition, as a result, as shown in Figure 4b, when the nitric oxide (NO) level was confirmed after inducing inflammation with LPS (lipopolysaccharide) in the RAW 264.7 cell line, all ISBP extracts reduced NO production in a dose-dependent manner. Confirmed.
종합적으로, 본 발명의 도두꼬투리 추출물 추출 방법은 도두꼬투리 내 지표 물질로서 루틴 함량을 가장 현저하게 증진시켰을 뿐만 아니라, 항산화 및 항염증과 같은 기능성 증진에도 우수한 효과를 나타냈다. Overall, the extract method of the present invention not only significantly increased the rutin content as an indicator substance in the pods, but also showed excellent effects in enhancing functionalities such as antioxidant and anti-inflammatory properties.
따라서, 본 발명은 신규 원료 소재인 도두꼬투리의 루틴 함량 및 기능성을 증가시키는 최적 추출법을 확립한 것이며, 이를 통해 향후 도두꼬투리의 원료 표준화의 기초 정보로 활용할 수 있는 기반을 마련한 바, 본 발명의 방법을 통해, 식품 소재 업계 및 가공 산업에서 높은 시장성을 가질 수 있다.Therefore, the present invention establishes an optimal extraction method for increasing the rutin content and functionality of soybean pods, a new raw material, and through this, a foundation that can be used as basic information for standardization of raw materials of soybean pods in the future is established. Through this, it can have high marketability in the food material industry and processing industry.
하기 본 발명의 방법에 따라 제조된 도두꼬투리 추출물의 제제예를 설명하나, 본 발명은 이를 한정하고자 함이 아닌 단지 구체적으로 설명하고자 함이다.Examples of formulations of the extract of Dodu pod prepared according to the method of the present invention will be described below, but the present invention is not intended to limit them, but only to specifically describe them.
제제예 1. 산제의 제조Formulation Example 1. Preparation of powder
도두꼬투리 추출물 분말 20 mgDodu
유당 100 mg
탈크 10 mg
상기의 성분들을 혼합하고 기밀포에 충진하여 산제를 제조한다.A powder is prepared by mixing the above ingredients and filling them in an airtight bag.
제제예 2. 정제의 제조Formulation Example 2. Preparation of tablets
도두꼬투리 추출물 분말 10 mgDodu
옥수수전분 100 mg
유당 100 mg
스테아린산 마그네슘 2 mg
상기의 성분들을 혼합한 후 통상의 정제의 제조방법에 따라서 타정하여 정제를 제조한다.After mixing the above ingredients, tablets are prepared by tableting according to a conventional tablet manufacturing method.
제제예 3. 캅셀제의 제조Formulation Example 3. Preparation of capsule formulation
도두꼬투리 추출물 분말 10 mgDodu
결정성 셀룰로오스 3 mg3 mg of crystalline cellulose
락토오스 14.8 mgLactose 14.8 mg
마그네슘 스테아레이트 0.2 mgMagnesium stearate 0.2 mg
통상의 캡슐제 제조방법에 따라 상기의 성분을 혼합하고 젤라틴 캡슐에 충전하여 캡슐제를 제조한다.Capsules are prepared by mixing the above ingredients and filling them into gelatin capsules according to a conventional capsule preparation method.
제제예 4. 주사제의 제조Formulation Example 4. Preparation of Injections
도두꼬투리 추출물 분말 10 mgDodu
만니톨 180 mgMannitol 180 mg
주사용 멸균 증류수 2974 mgSterile Distilled Water for Injection 2974 mg
Na2HPO4,12H2O 26 mgNa 2 HPO 4 , 12H 2 O 26 mg
통상의 주사제의 제조방법에 따라 1 앰플 당 상기의 성분 함량으로 제조한다.It is prepared with the above component content per 1 ampoule according to the conventional method for preparing injections.
제제예 5. 액제의 제조Formulation Example 5. Preparation of liquid formulation
도두꼬투리 추출물 분말 20 mgDodu
이성화당 10 gIsomerized sugar 10 g
만니톨 5 g5 g mannitol
정제수 적량Appropriate amount of purified water
통상의 액제의 제조방법에 따라 정제수에 각각의 성분을 가하여 용해시키고 레몬향을 적량 가한 다음 상기의 성분을 혼합한 다음 정제수를 가하여 전체를 정제수를 가하여 전체 100로 조절한 후 갈색병에 충진하여 멸균시켜 액제를 제조한다.According to the conventional manufacturing method of liquid formulations, each component is added to purified water to dissolve, lemon flavor is added in an appropriate amount, the above components are mixed, and purified water is added to adjust the total to 100, and then filled into a brown bottle for sterilization to prepare a liquid.
제제예 6. 건강기능식품의 제조Formulation Example 6. Manufacture of health functional food
도두꼬투리 추출물 1,000 mgDodu pod extract 1,000 mg
비타민 혼합물 적량Appropriate amount of vitamin mixture
비타민 A 아세테이트 70 ㎍Vitamin A Acetate 70 μg
비타민 E 1.0 mgVitamin E 1.0 mg
비타민 B1 0.13 mgVitamin B1 0.13 mg
비타민 B2 0.15 mgVitamin B2 0.15 mg
비타민 B6 0.5 mgVitamin B6 0.5 mg
비타민 B12 0.2 ㎍Vitamin B12 0.2 μg
비타민 C 10 mg
비오틴 10 ㎍10 μg of biotin
니코틴산아미드 1.7 mgNicotinamide 1.7 mg
엽산 50 ㎍
판토텐산 칼슘 0.5 mgCalcium Pantothenate 0.5 mg
무기질 혼합물 적량Appropriate amount of mineral mixture
황산제1철 1.75 mgFerrous sulfate 1.75 mg
산화아연 0.82 mgZinc Oxide 0.82 mg
탄산마그네슘 25.3 mgMagnesium Carbonate 25.3 mg
제1인산칼륨 15 mg
제2인산칼슘 55 mgDibasic Calcium Phosphate 55 mg
구연산칼륨 90 mgPotassium citrate 90 mg
탄산칼슘 100 mg
염화마그네슘 24.8 mgMagnesium Chloride 24.8 mg
상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 건강기능식품에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 건강기능식품 제조방법에 따라 상기의 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강기능식품 조성물 제조에 사용할 수 있다.Although the composition ratio of the above vitamin and mineral mixture is a mixture of ingredients suitable for health functional food in a preferred embodiment, the mixing ratio may be arbitrarily modified, and the above ingredients are mixed according to the normal health functional food manufacturing method. Then, granules are prepared and can be used for preparing a health functional food composition according to a conventional method.
제제예 7. 기능성 음료의 제조Formulation Example 7. Manufacturing of functional beverages
도두꼬투리 추출물 분말 1,000 mgDodu pod extract powder 1,000 mg
구연산 1,000 mgCitric Acid 1,000 mg
올리고당 100 g100 g of oligosaccharides
매실농축액 2 g2 g plum concentrate
타우린 1 g1 g of taurine
정제수를 가하여 전체 900 mLAdd purified water to total 900 mL
통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1 시간 동안 85℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2 L 용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 기능성 음료 조성물 제조에 사용한다.After mixing the above ingredients according to the usual health drink manufacturing method, stirring and heating at 85 ° C. for about 1 hour, the resulting solution is filtered and collected in a sterilized 2 L container, sealed and sterilized, and then refrigerated. It is used for preparing the functional beverage composition of the present invention.
상기 조성비는 비교적 기호음료에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 수요계층, 수요국가, 사용용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다.Although the composition ratio is a mixture of ingredients suitable for a relatively favorite beverage in a preferred embodiment, the mixing ratio may be arbitrarily modified according to regional and ethnic preferences such as the class of demand, the country of demand, and the purpose of use.
비록 본 발명이 상기에 언급된 바람직한 실시예로서 설명되었으나, 발명의 요지와 범위로부터 벗어남이 없이 다양한 수정이나 변형을 하는 것이 가능하다. 또한 첨부된 청구 범위는 본 발명의 요지에 속하는 이러한 수정이나 변형을 포함한다.Although the present invention has been described in terms of the preferred embodiments mentioned above, various modifications and variations are possible without departing from the spirit and scope of the invention. The appended claims also cover such modifications and variations as fall within the subject matter of this invention.
Claims (14)
[화학식 1]
.
A method for producing a Dodu pod extract with enhanced rutin content and functionality of Formula 1 below, comprising the step of extracting by adding a solvent to dried Dodu pod powder:
[Formula 1]
.
상기 기능성은 항산화 활성 및 항염증 활성인 것을 특징으로 하는, 방법.
According to claim 1,
Characterized in that the functionalities are antioxidant activity and anti-inflammatory activity.
상기 용매는 물, 탄소수 1 내지 4개의 저급 알코올 및 이들의 혼합용매로 이루어진 군으로부터 선택된 1 종 이상인 것을 특징으로 하는, 방법.
According to claim 1,
The method, characterized in that the solvent is at least one selected from the group consisting of water, lower alcohols having 1 to 4 carbon atoms, and mixed solvents thereof.
상기 탄소수 1 내지 4개의 저급 알코올은 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올 및 이소부탄올로 이루어진 군으로부터 선택된 1 종 이상인 것을 특징으로 하는, 방법.
According to claim 3,
The lower alcohol having 1 to 4 carbon atoms is at least one selected from the group consisting of methanol, ethanol, propanol, isopropanol, butanol and isobutanol.
상기 에탄올은 10% 내지 90%(v/v) 발효주정인 것을 특징으로 하는, 방법.
According to claim 4,
The method, characterized in that the ethanol is 10% to 90% (v / v) fermented alcohol.
상기 용매는 도두꼬투리 건조 분말 100 중량부에 대하여 500 내지 5,000중량부로 첨가되는 것을 특징으로 하는, 방법.
According to claim 1,
The method characterized in that the solvent is added in 500 to 5,000 parts by weight based on 100 parts by weight of the dry powder of soybean pods.
상기 추출 시간은 1 내지 100 시간이고, 추출 온도는 10 내지 120℃인 것을 특징으로 하는, 방법.
According to claim 1,
The extraction time is 1 to 100 hours, and the extraction temperature is 10 to 120 ° C.
상기 추출 단계 이후 원심분리후 여과하는 단계를 추가적으로 포함하고; 상기 여과에서 여과막의 공극 크기(pore size)는 0.01 내지 10 ㎛인 것을 특징으로 하는, 방법.
According to claim 1,
Further comprising the step of filtering after centrifugation after the extraction step; The pore size of the filtration membrane in the filtration is characterized in that 0.01 to 10 ㎛, method.
상기 여과 단계에서 여과된 여과액을 건조하여 분말화하는 단계를 추가적으로 포함하고; 상기 분말화는 분무건조, 동결건조, 진공건조 및 열풍건조 방법으로 이루어진 군으로부터 선택되는 방법으로 실시되는 것을 특징으로 하는, 방법.
According to claim 8,
Further comprising the step of drying and pulverizing the filtrate filtered in the filtration step; Characterized in that the powdering is carried out by a method selected from the group consisting of spray drying, freeze drying, vacuum drying and hot air drying methods.
An extract of Dodu pods with improved rutin content and functionality, prepared according to the method of any one of claims 1 to 9.
An antioxidant or anti-inflammatory health functional food comprising, as an active ingredient, a Dodu pod extract with enhanced rutin content and functionality, prepared according to the manufacturing method of any one of claims 1 to 9.
An antioxidant or anti-inflammatory cosmetic composition comprising, as an active ingredient, a Dodu pod extract with enhanced rutin content and functionality, prepared according to the manufacturing method of any one of claims 1 to 9.
An antioxidant and anti-inflammatory pharmaceutical composition comprising, as an active ingredient, a Dodu pod extract with enhanced rutin content and functionality, prepared according to the method of any one of claims 1 to 9.
An antioxidant and anti-inflammatory feed additive comprising, as an active ingredient, a Dodu pod extract with enhanced rutin content and functionality, prepared according to the manufacturing method of any one of claims 1 to 9.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210142124 | 2021-10-22 | ||
KR20210142124 | 2021-10-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230058291A true KR20230058291A (en) | 2023-05-03 |
Family
ID=86380358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220136458A KR20230058291A (en) | 2021-10-22 | 2022-10-21 | Novel Method for Preparing Immature Sword Bean Pod Extracts Having Increased Rutin Content and Functionality, and Immature Sword Bean Pod Extracts Prepared Thereby |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230058291A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101476218B1 (en) | 2013-03-21 | 2014-12-26 | 전남대학교산학협력단 | Compositions for Prevention and Treatment of Gastro-Intestinal Diseases Comprising Extract of Canavalia gladiata |
KR102248056B1 (en) | 2018-11-28 | 2021-05-03 | 황준환 | Cosmetic Composition containing Bottle Gourd Extract and Manufacturing method of thereof |
-
2022
- 2022-10-21 KR KR1020220136458A patent/KR20230058291A/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101476218B1 (en) | 2013-03-21 | 2014-12-26 | 전남대학교산학협력단 | Compositions for Prevention and Treatment of Gastro-Intestinal Diseases Comprising Extract of Canavalia gladiata |
KR102248056B1 (en) | 2018-11-28 | 2021-05-03 | 황준환 | Cosmetic Composition containing Bottle Gourd Extract and Manufacturing method of thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101976999B1 (en) | The method for preparing a Platycodon grandiflorum extract using a complex enzyme and a composition for improving antioxidant, whitening or wrinkles containing the same | |
KR101451298B1 (en) | Soybean leaves of the high-content isoflavone derivatives and preparing method thereof | |
KR20160144791A (en) | Composition for relieving menopausal symptom | |
JPWO2005112665A1 (en) | Composition containing processed sweet potato stems and leaves | |
KR101611853B1 (en) | Aster glehni fractions or compounds isolated therefrom having anti-inflammatory activity | |
KR101125224B1 (en) | A composition for skin anti-aging comprising extracts or fractions of Eremochloa ophiuroides as an active ingredient | |
KR101731152B1 (en) | Anti-diabetic composition containing the extract of actinidia arguta leaves or fractions thereof | |
KR101975296B1 (en) | Salty-taste Sauce Containing 5-deoxy-irilin B Having Angiotensin-I converting enzyme Inhibition Activity, Derived from Salicornia SPP. | |
KR101863117B1 (en) | Composition comprising Androsace umbellate extract, Vaccinium oldhami extract, and Deutzia crenata extract | |
KR20230058291A (en) | Novel Method for Preparing Immature Sword Bean Pod Extracts Having Increased Rutin Content and Functionality, and Immature Sword Bean Pod Extracts Prepared Thereby | |
KR20070113330A (en) | A composition containing ecklonia stolonifera extract for skin external application | |
KR101607188B1 (en) | Soybean stalks of the high-content isoflavone derivatives and preparing method thereof | |
KR101651100B1 (en) | ISOLATED SINGLE COMPOUND FROM Mori Cortex Radicis ITS APPLICATION IN TREATING AND PREVENTING OBESITY | |
EP3085226B1 (en) | Bean leaves or bean stems having high isoflavone derivative content, and method for preparing same | |
KR20120033443A (en) | Antifatigue composition comprising the extracts, fractions or isolated compounds of eisenia bicyclis and process for preparation thereof | |
WO2012077976A2 (en) | Anti-aging composition containing elaeocarpus petiolatus extract or fraction thereof as active ingredient | |
KR102229943B1 (en) | Composition for Skin-lightening and Improving Wrinkle Using an Extract of Maerua edulis | |
KR102092729B1 (en) | Pharmaceutical composition for preventing or treating liver damage comprising Curcuma longa extract | |
KR102468186B1 (en) | Composition for Skin-lightening Using an Extract of Lotus corniculatus var. japonica | |
KR102374474B1 (en) | Composition for Skin-lightening Using an Extract of Caulophyllum robustum | |
KR102012170B1 (en) | Composition comprising extracts of banana, cherry, and walnut for anti-skin aging | |
KR20230037000A (en) | Novel Method for Preparing Immature Sword Bean Pod Extracts Using Combination of Minerals Adding and Enzyme Process, and Immature Sword Bean Pod Extracts Prepared Thereby | |
KR20180104960A (en) | Composition comprising extracts of banana, cherry, and walnut for anti-skin aging | |
KR20170091238A (en) | Composition containing complex extracts including Acer saccharum Acerpseudo sibolianum and Acer ginnala with antioxidant activity | |
KR101651105B1 (en) | ISOLATED SINGLE COMPOUND FROM Mori Cortex Radicis ITS APPLICATION IN TREATING AND PREVENTING OBESITY |